出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年3月
Medical Device Contract Manufacturing Market – Global Forecast to 2029
医療機器受託製造市場 : デバイスタイプ［IVD、心臓血管、ドラッグデリバリー（自動注射器、輸液デバイス）、糖尿病ケア、整形外科、眼科、内視鏡検査、外科］、デバイスクラス（I、II、III）、サービス – 2029年までの世界予測
Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Drug Delivery (Autoinjectors, Infusion Device), Diabetes Care, Orthopedic, Ophthalmology, Endoscopy, Surgical), Device Class (I, II, III), Services -Global Forecast to 2029
| ページ数 | 430 |
| 図表数 | 472 |
| 価格 | |
| シングルユーザライセンス | USD 4,950 |
| マルチユーザライセンス（5名） | USD 6,650 |
| コーポレート（サイト）ライセンス | USD 8,150 |
| エンタープライズライセンス | USD 10,000 |
| 種別 | 英文調査報告書 |
Report Overview
The global medical device contract manufacturing market is projected to reach 149.4 Billion in 2029 from USD 78.9 Billion in 2023, at a CAGR of 11.4% between 2024 and 2029.
世界の医療機器受託製造市場は、2023年の789億米ドルから2029年には1,494億米ドルに達し、2024年から2029年までのCAGRは11.4%になると予測されています。
The market is anticipated to grow as a result of development continuous advancements in medical devices felid such as robotics and minimally invasive surgery, artificial intelligence (AI) in medical devices, telemedicine and remote patient monitoring is expected to drive the market growth.
Ageing populations with rising need for medical diagnostics further contribute to market growth. On the other hand, stringent regulatory compliance and complexities in supply chain management are expected to limit market growth to a certain extent.
“Based on the device type, the cardiovascular device segment is expected to grow by the highest CAGR in the medical device contract manufacturing market.”
Devices like pacemakers regulate irregular heartbeats, stents open blocked arteries, and defibrillators prevent sudden cardiac arrest. This translates to a reduced risk of mortality and improved cardiovascular health also advancements in technologies like balloon angioplasty and stent placement allow for less invasive procedures compared to traditional open-heart surgery. This leads to quicker recovery times, reduced pain, and minimized scarring which is expected to drive the market growth.
“The device and component manufacturing services segment is expected to grow with the highest CAGR in the device development and manufacturing services segment in the medical device contract manufacturing market.”
Device and component manufacturing services offer several significant advantages which includes reduced costs, contract manufacturers (CMs) specialize in high-volume production, allowing them to leverage economies of scale and negotiate better rates with material suppliers. This translates to cost savings for medical device companies that may not have the resources to establish their own large-scale manufacturing facilities.
“Based on the class of device, the class III segment is expected to grow by the highest CAGR in the medical device contract manufacturing market. Out of the other class of device, class III is expected to grow at the highest CAGR from 2024 to 2029.”
The stringent regulatory requirements for class III devices incentivize manufacturers to invest heavily in research and development. This leads to continuous innovation and the creation of new, more sophisticated medical technologies that push the boundaries of healthcare possibilities which is expected to drive the medical device contract manufacturing market.
“Asia-Pacific to grow with the highest CAGR in the medical device contract manufacturing market during the forecast period.”
The rapid population growth, increasing awareness about medical devices, and a rising middle class translate to a strong demand for MDCM services across Asia Pacific. Also global leaders in medical device contract manufacturing are establishing their presence in APAC, introducing advanced devices, innovative software, and diverse biocompatible materials.
Europe was the largest segment in the medical device contract manufacturing market in 2023. The Germany accounted for the larger share of the European medical device contract manufacturing market in 2023. The rising number of chronic diseases and and growing awareness regarding medical devices is expected to drive the market growth in Europen market.
A breakdown of the primary participants (supply-side) for the medical device contract manufacturing market referred to for this report is provided below:
• By Company Type: Tier 1–40%, Tier 2–35%, and Tier 3–25%
• By Designation: C-level–30%, Director Level–55%, and Others–15%
• By Region: North America–20%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East & Africa-30%.
Prominent players in the medical device contract manufacturing market include Flex Ltd. (Singapore), Jabil Inc. (US), TE Connectivity Ltd. (Switzerland), Sanmina Corporation (US), Nipro Corporation (Japan), Celestica Inc. (Canada), Plexus Corp. (US), Integer Holdings Corporation (US), West Pharmaceutical Services, Inc. (US), Benchmark Electronics Inc. (US), Recipharm AB (Sweden), Gerresheimer AG (Germany), Kimball Electronics Inc. (US), Nortech Systems, Inc. (US), Nemera Development S.A. (France), Viant Medical Holdings, Inc. (US), Tecomet, Inc. (US), SMC Ltd. (US), Phillips-Medisize Corporation (US), Tessy Plastics Corp. (US), Carclo Plc (UK), Nolato GW, Inc. (US), MeHow (China), Tekni-Plex (US), and Peter’s Technology (China).
Research Coverage:
The report analyzes the medical device contract manufacturing market and aims at estimating the market size and future growth potential of this market based on various segments such as device type, class of device, service and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, product/service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall medical device contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (growth in medical devices market in developing countries, adoption of robotics and automation in manufacturing processes, technological advancements in medical device modalities, impact of industry 4.0 on the medical device industry), restraints (consolidation in medical devices market by acquiring small and medium-sized companies), opportunities (increasing healthcare expenditure, infrastructure, and awareness in developing countries, rising geriatric population and its associated diseases) and challenges (lack of constant innovation to balance technological capabilities against costs)
• Market Penetration: It includes extensive information on product portfolios offered by the major players in the global medical device contract manufacturing market. The report includes various segments in market device type, class of device, service and region
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical device contract manufacturing market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by device type, class of device, service and region
• Market Diversification: Comprehensive information about newly launched product and services, expanding markets, current advancements, and investments in the global medical device contract manufacturing market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of product and services, and capacities of the major competitors in the global medical device contract manufacturing market.
Table of Contents
1 INTRODUCTION 52
1.1 STUDY OBJECTIVES 52
1.2 MARKET DEFINITION 52
1.2.1 INCLUSIONS & EXCLUSIONS 52
1.3 MARKET SCOPE 53
1.3.1 MARKETS COVERED 53
1.3.2 REGIONS COVERED 54
1.3.3 YEARS CONSIDERED 54
1.3.4 CURRENCY CONSIDERED 55
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 55
1.4 STAKEHOLDERS 55
1.5 SUMMARY OF CHANGES 55
1.5.1 RECESSION IMPACT 56
2 RESEARCH METHODOLOGY 57
2.1 RESEARCH DATA 57
FIGURE 1 RESEARCH DESIGN 57
2.1.1 SECONDARY DATA 58
2.1.1.1 Key data from secondary sources 59
2.1.2 PRIMARY DATA 60
FIGURE 2 PRIMARY SOURCES 60
2.1.2.1 Key data from primary sources 61
2.1.2.2 Key industry insights 62
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 62
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 63
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 63
2.2 MARKET SIZE ESTIMATION 64
FIGURE 6 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 64
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: FLEX, LTD. 65
FIGURE 8 SUPPLY-SIDE ANALYSIS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET (2023) 66
FIGURE 9 DEMAND-SIDE ESTIMATION FOR MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 67
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029) 68
FIGURE 11 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 68
FIGURE 12 TOP-DOWN APPROACH 69
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 70
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 70
2.4 MARKET SHARE ESTIMATION 70
2.5 STUDY ASSUMPTIONS 71
2.6 RESEARCH LIMITATIONS 71
2.6.1 METHODOLOGY-RELATED LIMITATIONS 71
2.6.2 SCOPE-RELATED LIMITATIONS 71
2.7 RISK ASSESSMENT 72
TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 72
2.8 RECESSION IMPACT ANALYSIS 72
3 EXECUTIVE SUMMARY 73
FIGURE 14 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION) 73
FIGURE 15 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2024 VS. 2029 (USD MILLION) 74
FIGURE 16 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024 VS. 2029 (USD MILLION) 75
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 76
4 PREMIUM INSIGHTS 77
4.1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET OVERVIEW 77
FIGURE 18 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL DEVICE MODALITIES TO DRIVE MARKET 77
4.2 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE AND COUNTRY (2023) 78
FIGURE 19 CLASS III MEDICAL DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2023 78
4.3 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 79
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 79
4.4 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 80
FIGURE 21 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 80
4.5 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: REGIONAL MIX 81
FIGURE 22 ASIA PACIFIC WILL CONTINUE TO DOMINATE MARKET IN 2029 81
5 MARKET OVERVIEW 82
5.1 INTRODUCTION 82
5.2 MARKET DYNAMICS 82
FIGURE 23 MARKET DYNAMICS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 82
5.2.1 DRIVERS 83
5.2.1.1 Growing medical devices market in developing countries 83
TABLE 3 GDP GROWTH FORECAST: COMPARISON OF INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040 (FORECAST) 83
5.2.1.2 Adoption of robotics and automation in manufacturing 84
5.2.1.3 Technological advancements in medical device modalities 85
FIGURE 24 FACTORS DRIVING DEMAND FOR CONTRACT MANUFACTURING 86
5.2.1.4 Impact of Industry 4.0 on medical device industry 86
5.2.2 RESTRAINTS 87
5.2.2.1 Consolidation in medical devices market 87
TABLE 4 KEY ACQUISITIONS IN MEDICAL DEVICE INDUSTRY 87
5.2.3 OPPORTUNITIES 88
5.2.3.1 Increasing healthcare expenditure, infrastructure, and awareness in developing economies 88
TABLE 5 HEALTHCARE EXPENDITURE (%), BY COUNTRY (2010 TO 2021) 88
TABLE 6 HEALTHCARE EXPENDITURE PER CAPITA (USD),(2015 AND 2050) 89
5.2.3.2 Rising geriatric population and increasing incidence of associated diseases 89
TABLE 7 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2019 VS. 2050 89
TABLE 8 AVERAGE LIFE EXPECTANCY, 2023 (FORECAST) 90
5.2.4 CHALLENGES 90
5.2.4.1 Lack of constant innovation to balance technological capabilities against costs 90
5.2.5 INDUSTRY TRENDS 91
5.2.5.1 Increasing consolidation of OEMs and contract manufacturers 91
TABLE 9 KEY EXAMPLES OF OEM CONSOLIDATION IN LAST FIVE YEARS 91
TABLE 10 KEY EXAMPLES OF CMO CONSOLIDATION 91
5.2.5.2 Growing interest of private equity firms in medical device contract manufacturing 92
TABLE 11 KEY INVESTMENTS BY PRIVATE EQUITY FIRMS 92
5.2.5.3 Outsourcing of medical device contract manufacturing services 93
TABLE 12 EXAMPLES OF KEY COLLABORATIONS AND AGREEMENTS 93
5.2.6 INDUSTRY 5.0 93
5.3 PRICING ANALYSIS 94
5.3.1 AVERAGE SELLING PRICE TREND FOR MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES, BY DEVICE 94
TABLE 13 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY DEVICE 94
5.3.2 AVERAGE SELLING PRICE TREND, BY REGION 95
TABLE 14 AVERAGE COST RANGE OF MEDICAL DEVICE CONTRACT MANUFACTURING PRODUCTS, 2023 (USD) 95
5.4 VALUE CHAIN ANALYSIS 96
FIGURE 25 VALUE CHAIN ANALYSIS: MEDICAL DEVICE CONTRACT MANUFACTURING (2023) 96
5.5 PORTER’S FIVE FORCES ANALYSIS 97
TABLE 15 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS 97
5.5.1 THREAT OF NEW ENTRANTS 97
5.5.1.1 Growth in medical device industry 97
5.5.1.2 Demand for compact, cost-effective, and non-invasive devices 97
5.5.1.3 Consolidation 97
5.5.1.4 Poor financing environment 97
5.5.1.5 Stringent regulatory environment 98
5.5.2 THREAT OF SUBSTITUTES 98
5.5.2.1 Undesirability of existing portfolios 98
5.5.2.2 Combination and integration of multiple technologies 98
5.5.2.3 Availability of alternatives 98
5.5.3 BARGAINING POWER OF SUPPLIERS 98
5.5.3.1 Big medical device contract manufacturing companies 98
5.5.3.2 Institutional technology providers 98
5.5.3.3 Substantially innovative technologies 99
5.5.3.4 Dysfunctional companies 99
5.5.3.5 Academic inventors 99
5.5.4 BARGAINING POWER OF BUYERS 99
5.5.4.1 Few buyers and many sellers 99
5.5.4.2 Buy-out threat 99
5.5.4.3 Demand for new pipeline services 99
5.5.4.4 Point of differentiation 99
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 100
5.5.5.1 Similar spectrum of services offered 100
5.5.5.2 Similar funding source 100
5.5.5.3 Self-funded big contract manufacturers 100
5.5.5.4 Highly fragmented industry 100
5.6 TARIFF AND REGULATORY LANDSCAPE 100
5.6.1 REGULATORY ANALYSIS 100
5.6.1.1 North America 100
5.6.1.1.1 US 100
TABLE 16 US: CLASSIFICATION OF MEDICAL EQUIPMENT 100
TABLE 17 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 101
5.6.1.1.2 Canada 101
TABLE 18 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 101
5.6.1.2 Europe 102
TABLE 19 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 102
5.6.1.3 Asia Pacific 102
5.6.1.3.1 Japan 102
TABLE 20 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 103
5.6.1.3.2 China 103
TABLE 21 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 103
5.6.1.3.3 India 104
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 105
TABLE 25 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 26 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
5.7 KEY CONFERENCES AND EVENTS, 2024–2025 107
TABLE 27 DETAILED LIST OF CONFERENCES AND EVENTS 107
5.8 PATENT ANALYSIS 108
5.8.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICES 108
FIGURE 26 PATENT PUBLICATION TRENDS (JANUARY 2013–NOVEMBER 2023) 108
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 108
FIGURE 27 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL DEVICE PATENTS (JANUARY 2013–NOVEMBER 2023) 109
FIGURE 28 TOP 10 APPLICANT COUNTRIES/REGIONS FOR MEDICAL DEVICE PATENTS (JANUARY 2013–NOVEMBER 2023) 109
TABLE 28 MEDICAL DEVICES: LIST OF MAJOR PATENTS 110
5.9 TECHNOLOGY ANALYSIS 111
5.9.1 KEY TECHNOLOGIES 111
5.9.1.1 Digital transformation 111
5.9.1.2 Robotics and automation 111
5.9.2 ADJACENT TECHNOLOGIES 112
5.9.2.1 Artificial Intelligence 112
5.9.2.2 Big data 112
5.9.3 COMPLEMENTARY TECHNOLOGIES 112
5.9.3.1 5G 112
5.10 SUPPLY CHAIN ANALYSIS 113
FIGURE 29 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: SUPPLY CHAIN (2023) 113
5.11 ECOSYSTEM ANALYSIS 113
TABLE 29 ROLE IN ECOSYSTEM: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2023 113
FIGURE 30 ROLE IN ECOSYSTEM: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2023 114
5.12 TRADE ANALYSIS 115
TABLE 30 IMPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2023 115
TABLE 31 EXPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2023 115
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 116
FIGURE 31 REVENUE SHIFTS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 116
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 116
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 116
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES 116
TABLE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES 117
5.14.2 BUYING CRITERIA 117
FIGURE 33 KEY BUYING CRITERIA FOR MEDICAL DEVICES 117
TABLE 33 KEY BUYING CRITERIA FOR MEDICAL DEVICES 117
5.15 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 118
FIGURE 34 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 118
5.16 UNMET NEEDS/END-USER EXPECTATIONS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 118
5.17 APPLICATION OF ARTIFICIAL INTELLIGENCE IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 119
5.18 CASE STUDY ANALYSIS 119
5.18.1 JABIL INC. AND HEARTWARE INTERNATIONAL 119
5.18.2 FLEX LTD. IN MEDICAL DEVICE MANUFACTURING 120
5.18.3 BRINGING AN INNOVATIVE INSULIN PUMP TO MARKET 120
5.19 INVESTMENT AND FUNDING SCENARIO 121
TABLE 34 INVESTMENT/VENTURE CAPITAL SCENARIO IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2018–2022 121
6 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE 122
6.1 INTRODUCTION 123
TABLE 35 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 123
6.2 IVD DEVICES 124
TABLE 36 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 124
TABLE 37 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 125
6.2.1 IVD CONSUMABLES 126
6.2.1.1 Increasing demand for reagents & kits to drive market 126
TABLE 38 IVD CONSUMABLES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 127
6.2.2 IVD EQUIPMENT 127
6.2.2.1 Advances in life sciences research to support market growth 127
TABLE 39 IVD EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 128
6.3 DIAGNOSTIC IMAGING DEVICES 129
6.3.1 ADOPTION OF NEW AND ADVANCED DIAGNOSTIC IMAGING SYSTEMS IN DEVELOPING COUNTRIES TO SUPPORT MARKET GROWTH 129
TABLE 40 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIAGNOSTIC IMAGING DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 130
6.4 CARDIOVASCULAR DEVICES 131
6.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO PROPEL MARKET 131
TABLE 41 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015–2035 131
TABLE 42 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CARDIOVASCULAR DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 132
6.5 DRUG DELIVERY DEVICES 133
TABLE 43 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 133
TABLE 44 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 134
6.5.1 INFUSION DEVICES & ADMINISTRATION SETS 135
6.5.1.1 Rising incidence of chronic diseases to fuel market growth 135
TABLE 45 INFUSION DEVICES AND ADMINISTRATION SETS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 136
6.5.2 SYRINGES 137
6.5.2.1 Increasing incidence of needlestick injuries to hamper market growth 137
TABLE 46 SYRINGES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 138
6.5.3 INHALERS 139
6.5.3.1 High prevalence of asthma, COPD, and cystic fibrosis to aid market growth 139
TABLE 47 INHALERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 140
6.5.4 AUTOINJECTORS & PEN INJECTORS 141
6.5.4.1 Rising number of regulatory approvals for new drug therapies to support market growth 141
TABLE 48 RECENT APPROVALS FOR AUTOINJECTORS AND PEN INJECTORS GLOBALLY 141
TABLE 49 AUTOINJECTORS & PEN INJECTORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 142
6.6 ORTHOPEDIC DEVICES 143
6.6.1 HIGH PREVALENCE OF ORTHOPEDIC CONDITIONS TO DRIVE MARKET 143
TABLE 50 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ORTHOPEDIC DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 144
6.7 RESPIRATORY CARE DEVICES 145
6.7.1 COVID-19 BOOSTED DEMAND FOR CONTRACT MANUFACTURING OF RESPIRATORY CARE DEVICES 145
TABLE 51 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR RESPIRATORY CARE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 146
6.8 OPHTHALMOLOGY DEVICES 147
6.8.1 INCREASING PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET 147
TABLE 52 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OPHTHALMOLOGY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 148
6.9 SURGICAL DEVICES 149
6.9.1 INCREASING NUMBER OF SURGICAL PROCEDURES TO FUEL MARKET GROWTH 149
TABLE 53 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 150
6.10 DIABETES CARE DEVICES 151
6.10.1 RISING PREVALENCE OF DIABETES TO PROPEL MARKET 151
TABLE 54 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2021 VS. 2045 151
TABLE 55 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIABETES CARE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 152
6.11 DENTAL DEVICES 153
6.11.1 RISING INCIDENCE OF DENTAL DISORDERS TO SUPPORT MARKET GROWTH 153
TABLE 56 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DENTAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 154
6.12 ENDOSCOPY & LAPAROSCOPY DEVICES 155
6.12.1 RISING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET 155
TABLE 57 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ENDOSCOPY & LAPAROSCOPY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 156
6.13 GYNECOLOGY/UROLOGY DEVICES 157
6.13.1 GROWING AWARENESS AND PREVENTIVE CHECKUPS FOR LATE-PHASE DIAGNOSIS OF STDS TO PROPEL MARKET 157
FIGURE 35 US: SEXUALLY TRANSMITTED DISEASE CASES, 2017 VS. 2021 157
TABLE 58 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR GYNECOLOGY/UROLOGY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 158
6.14 PERSONAL CARE DEVICES 159
6.14.1 SHIFT IN CONSUMPTION PATTERN TOWARD PREMIUM PERSONAL CARE PRODUCTS TO FUEL MARKET 159
TABLE 59 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PERSONAL CARE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 160
6.15 NEUROLOGY DEVICES 161
6.15.1 RISING PREVALENCE OF NEUROLOGICAL DISEASES TO DRIVE MARKET 161
TABLE 60 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR NEUROLOGY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 162
6.16 PATIENT MONITORING DEVICES 163
6.16.1 GROWING AVAILABILITY OF INTEGRATED MONITORING TECHNOLOGY TO AID MARKET 163
TABLE 61 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT MONITORING DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 164
6.17 PATIENT ASSISTIVE DEVICES 165
6.17.1 RISING GERIATRIC POPULATION TO PROPEL MARKET 165
TABLE 62 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT ASSISTIVE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 166
6.18 OTHER DEVICES 167
TABLE 63 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 167
7 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE 168
7.1 INTRODUCTION 169
TABLE 64 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 169
7.2 COMPARISON OF DEVICE CLASSIFICATION, BY COUNTRY/REGION 169
7.2.1 US 169
7.2.1.1 Class I: General controls 169
7.2.1.2 Class II: General controls with special controls 169
7.2.1.3 Class III: General controls, special controls, and premarket approval 170
7.2.2 CANADA 170
7.2.3 EUROPEAN UNION AND EUROPEAN FREE TRADE ASSOCIATION 170
7.2.3.1 Class I medical devices 170
7.2.3.1.1 Class Is: Noninvasive devices 171
7.2.3.1.2 Class Ir: Reusable surgical instruments 171
7.2.3.1.3 Class Im: Low-risk measuring devices 171
7.2.3.2 Class IIa medical devices 171
7.2.3.3 Class IIb medical devices 171
7.2.3.4 Class III medical devices 171
7.2.4 ASIA PACIFIC 172
7.2.4.1 China 172
7.2.4.2 India 172
7.2.4.3 Japan 173
7.2.4.4 Australia 173
7.3 CLASS II MEDICAL DEVICES 174
7.3.1 HIGH-VOLUME UTILIZATION OF CLASS II MEDICAL DEVICES BY END USERS TO SUPPORT MARKET GROWTH 174
TABLE 65 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS II MEDICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 175
7.4 CLASS I MEDICAL DEVICES 176
7.4.1 POSSESS MINIMUM POTENTIAL TO HARM USERS 176
TABLE 66 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS I MEDICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 177
7.5 CLASS III MEDICAL DEVICES 178
7.5.1 INVOLVE HIGHEST LEVEL OF HEALTH RISKS TO USERS 178
TABLE 67 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS III MEDICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 179
8 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE 180
8.1 INTRODUCTION 181
FIGURE 36 STAGES INVOLVED IN CONTRACT MANUFACTURING OF MEDICAL DEVICES 181
TABLE 68 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 181
8.2 DEVICE DEVELOPMENT AND MANUFACTURING 182
TABLE 69 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 182
TABLE 70 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY COUNTRY, 2021–2029 (USD MILLION) 183
8.2.1 DEVICE AND COMPONENT MANUFACTURING 184
8.2.1.1 Development of new technologies necessitates specialized device manufacturing capabilities 184
TABLE 71 DEVICE AND COMPONENT MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 185
8.2.2 PROCESS DEVELOPMENT 186
8.2.2.1 Growing demand for complex products to drive growth 186
FIGURE 37 PROCESS DEVELOPMENT SERVICES FOR MEDICAL DEVICES 186
TABLE 72 PROCESS DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 188
8.2.3 DEVICE ENGINEERING 189
8.2.3.1 Efficiency and cost-effectiveness of device engineering services to propel segment 189
TABLE 73 DEVICE ENGINEERING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 190
8.3 QUALITY MANAGEMENT 191
TABLE 74 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 191
TABLE 75 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY COUNTRY, 2021–2029 (USD MILLION) 192
8.3.1 PACKAGING VALIDATION 193
8.3.1.1 Increasing product safety concerns for medical devices to aid market 193
TABLE 76 PACKAGING VALIDATION SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 193
8.3.2 INSPECTION AND TESTING 194
8.3.2.1 Increased technological expertise in testing services to eliminate large capital and overhead investments 194
TABLE 77 INSPECTION AND TESTING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 195
8.3.3 STERILIZATION SERVICES 196
8.3.3.1 Need to meet regulatory requirements for sterility in medical devices to support market growth 196
TABLE 78 MEDICAL DEVICE STERILIZATION PATENTS PUBLISHED BY MAJOR COMPANIES WORLDWIDE 196
TABLE 79 STERILIZATION SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 197
8.4 PACKAGING AND ASSEMBLY SERVICES 198
FIGURE 38 FINAL ASSEMBLY SERVICES IN GLOBAL VALUE CHAIN OF MEDICAL DEVICES 198
TABLE 80 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 198
TABLE 81 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY COUNTRY, 2021–2029 (USD MILLION) 199
8.4.1 PRIMARY AND SECONDARY PACKAGING 200
8.4.1.1 Growing concerns for patient safety to aid growth 200
TABLE 82 PRIMARY AND SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 200
8.4.2 LABELING 201
8.4.2.1 Export bans and product recalls due to improper labeling to support market 201
TABLE 83 LABELING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 201
8.4.3 OTHER PACKAGING AND ASSEMBLY SERVICES 202
TABLE 84 OTHER PACKAGING AND ASSEMBLY SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 202
8.5 OTHER SERVICES 203
TABLE 85 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER SERVICES, BY COUNTRY, 2021–2029 (USD MILLION) 203
9 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION 204
9.1 INTRODUCTION 205
FIGURE 39 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 205
TABLE 86 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2029 (USD MILLION) 206
9.2 ASIA PACIFIC 206
9.2.1 ASIA PACIFIC: RECESSION IMPACT 206
FIGURE 40 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SNAPSHOT 207
TABLE 87 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 208
TABLE 88 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 209
TABLE 89 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 209
TABLE 90 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 210
TABLE 91 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 210
TABLE 92 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 211
TABLE 93 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 211
TABLE 94 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 212
TABLE 95 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 212
9.2.2 CHINA 212
9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market 212
TABLE 96 CHINA: KEY MACROINDICATORS 213
TABLE 97 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 214
TABLE 98 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 214
TABLE 99 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 215
TABLE 100 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 215
TABLE 101 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 216
TABLE 102 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 216
TABLE 103 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 217
TABLE 104 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 217
9.2.3 JAPAN 217
9.2.3.1 Universal healthcare reimbursement policies to propel market 217
TABLE 105 JAPAN: KEY MACROINDICATORS 218
TABLE 106 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 219
TABLE 107 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 219
TABLE 108 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 220
TABLE 109 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 220
TABLE 110 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 221
TABLE 111 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 221
TABLE 112 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 222
TABLE 113 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 222
9.2.4 MALAYSIA & SINGAPORE 222
9.2.4.1 Increasing R&D activities and investments by established players to augment market 222
TABLE 114 MALAYSIA: KEY MACROINDICATORS 223
TABLE 115 SINGAPORE: KEY MACROINDICATORS 223
TABLE 116 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 224
TABLE 117 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 224
TABLE 118 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 225
TABLE 119 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 225
TABLE 120 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 226
TABLE 121 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 226
TABLE 122 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 227
TABLE 123 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 227
9.2.5 INDIA 227
9.2.5.1 Rising contract manufacturing capabilities to support market growth 227
TABLE 124 INDIA: KEY MACROINDICATORS 228
TABLE 125 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 229
TABLE 126 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 229
TABLE 127 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 230
TABLE 128 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 230
TABLE 129 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 231
TABLE 130 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 231
TABLE 131 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 232
TABLE 132 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 232
9.2.6 AUSTRALIA & NEW ZEALAND 232
9.2.6.1 Need for advanced medical and diagnostic tools to fuel market growth 232
TABLE 133 AUSTRALIA: KEY MACROINDICATORS 233
TABLE 134 NEW ZEALAND: KEY MACROINDICATORS 233
TABLE 135 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 234
TABLE 136 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 234
TABLE 137 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 235
TABLE 138 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 235
TABLE 139 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 236
TABLE 140 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 236
TABLE 141 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 237
TABLE 142 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 237
9.2.7 SOUTH KOREA 237
9.2.7.1 High-value imports from other countries to offer growth opportunities 237
TABLE 143 SOUTH KOREA: KEY MACROINDICATORS 238
TABLE 144 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 238
TABLE 145 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 146 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 147 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 239
TABLE 148 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 240
TABLE 149 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 240
TABLE 150 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 241
TABLE 151 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 241
9.2.8 REST OF ASIA PACIFIC 241
TABLE 152 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 242
TABLE 153 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 242
TABLE 154 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 243
TABLE 155 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 243
TABLE 156 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 244
TABLE 157 REST OF ASIA PACIFIC: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 244
TABLE 158 REST OF ASIA PACIFIC: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 245
TABLE 159 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 245
9.3 NORTH AMERICA 246
9.3.1 NORTH AMERICA: RECESSION IMPACT 246
TABLE 160 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 246
TABLE 161 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 247
TABLE 162 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 247
TABLE 163 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 248
TABLE 164 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 248
TABLE 165 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 249
TABLE 166 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 249
TABLE 167 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 250
TABLE 168 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 250
9.3.2 US 250
9.3.2.1 Presence of stringent government regulations to drive market 250
TABLE 169 US: KEY MACROINDICATORS 251
TABLE 170 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 252
TABLE 171 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 252
TABLE 172 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 253
TABLE 173 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 253
TABLE 174 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 254
TABLE 175 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 254
TABLE 176 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 255
TABLE 177 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 255
9.3.3 CANADA 255
9.3.3.1 Strong presence of key contract manufacturing companies to augment market 255
TABLE 178 CANADA: KEY MACROINDICATORS 256
TABLE 179 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 257
TABLE 180 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 257
TABLE 181 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 258
TABLE 182 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 258
TABLE 183 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 259
TABLE 184 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 259
TABLE 185 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 260
TABLE 186 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 260
9.4 EUROPE 261
9.4.1 EUROPE: RECESSION IMPACT 261
TABLE 187 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 262
TABLE 188 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 263
TABLE 189 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 263
TABLE 190 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 264
TABLE 191 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 264
TABLE 192 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 265
TABLE 193 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 265
TABLE 194 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 266
TABLE 195 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 266
9.4.2 GERMANY 266
9.4.2.1 Presence of major device manufacturers and high healthcare expenditure to support market growth 266
TABLE 196 GERMANY: KEY MACROINDICATORS 267
TABLE 197 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 268
TABLE 198 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 268
TABLE 199 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 269
TABLE 200 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 269
TABLE 201 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 270
TABLE 202 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 270
TABLE 203 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 271
TABLE 204 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 271
9.4.3 FRANCE 271
9.4.3.1 Increasing government pressure for healthcare cost reduction and budgetary constraints to support market growth 271
TABLE 205 FRANCE: KEY MACROINDICATORS 272
TABLE 206 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 272
TABLE 207 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 273
TABLE 208 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 273
TABLE 209 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 273
TABLE 210 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 274
TABLE 211 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 274
TABLE 212 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 275
TABLE 213 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 275
9.4.4 UK 275
9.4.4.1 Rising number of accredited clinical laboratories and hospital laboratories to propel market 275
TABLE 214 UK: KEY MACROINDICATORS 276
TABLE 215 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 277
TABLE 216 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 277
TABLE 217 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 278
TABLE 218 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 278
TABLE 219 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 279
TABLE 220 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 279
TABLE 221 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 280
TABLE 222 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 280
9.4.5 ITALY 280
9.4.5.1 Healthcare coverage for all citizens and foreign residents to increase demand for medical devices 280
TABLE 223 ITALY: KEY MACROINDICATORS 281
TABLE 224 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 282
TABLE 225 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 282
TABLE 226 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 283
TABLE 227 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 283
TABLE 228 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 284
TABLE 229 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 284
TABLE 230 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 285
TABLE 231 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 285
9.4.6 SPAIN 285
9.4.6.1 Increasing adoption of home-based medical devices to drive market 285
TABLE 232 SPAIN: KEY MACROINDICATORS 286
TABLE 233 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 286
TABLE 234 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 287
TABLE 235 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 287
TABLE 236 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 287
TABLE 237 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 288
TABLE 238 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 288
TABLE 239 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 289
TABLE 240 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 289
9.4.7 REST OF EUROPE 289
TABLE 241 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 290
TABLE 242 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 290
TABLE 243 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 291
TABLE 244 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 291
TABLE 245 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 292
TABLE 246 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 292
TABLE 247 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 293
TABLE 248 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 293
9.5 LATIN AMERICA 294
9.5.1 LATIN AMERICA: RECESSION IMPACT 294
TABLE 249 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 294
TABLE 250 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 295
TABLE 251 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 295
TABLE 252 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 296
TABLE 253 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 296
TABLE 254 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 297
TABLE 255 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 297
TABLE 256 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 298
TABLE 257 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 298
9.5.2 MEXICO 298
9.5.2.1 Important destination for contract manufacturers 298
TABLE 258 MEXICO: KEY MACROINDICATORS 299
TABLE 259 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 299
TABLE 260 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 300
TABLE 261 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 300
TABLE 262 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 300
TABLE 263 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 301
TABLE 264 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 301
TABLE 265 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 266 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 302
9.5.3 BRAZIL 302
9.5.3.1 Favorable government initiatives and willingness to pay for better healthcare to boost market 302
TABLE 267 BRAZIL: KEY MACROINDICATORS 303
TABLE 268 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 304
TABLE 269 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 304
TABLE 270 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 305
TABLE 271 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 305
TABLE 272 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 306
TABLE 273 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 306
TABLE 274 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 307
TABLE 275 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 307
9.5.4 REST OF LATIN AMERICA 307
TABLE 276 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 308
TABLE 277 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 308
TABLE 278 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 309
TABLE 279 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 309
TABLE 280 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 310
TABLE 281 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 310
TABLE 282 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 311
TABLE 283 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 311
9.6 MIDDLE EAST & AFRICA 312
9.6.1 GROWING HEALTHCARE INVESTMENTS AND IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET 312
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 312
TABLE 284 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 313
TABLE 285 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 313
TABLE 286 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 314
TABLE 287 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 314
TABLE 288 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 315
TABLE 289 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 315
TABLE 290 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 316
TABLE 291 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 316
9.7 GCC COUNTRIES 317
9.7.1 INCREASING HEALTHCARE INFRASTRUCTURE DEVELOPMENT TO SUPPORT MARKET GROWTH 317
9.7.2 GCC COUNTRIES: RECESSION IMPACT 317
TABLE 292 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 318
TABLE 293 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 318
TABLE 294 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 319
TABLE 295 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 319
TABLE 296 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 320
TABLE 297 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 320
TABLE 298 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 321
TABLE 299 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 321
10 COMPETITIVE LANDSCAPE 322
10.1 OVERVIEW 322
10.1.1 KEY PLAYER STRATEGIES/RIGHT TO WIN 322
TABLE 300 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MEDICAL DEVICE CONTRACT MANUFACTURERS 323
10.2 REVENUE SHARE ANALYSIS 324
FIGURE 41 REVENUE SHARE ANALYSIS FOR KEY COMPANIES, 2020–2023 324
10.3 MARKET SHARE ANALYSIS 325
FIGURE 42 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2023) 325
TABLE 301 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION 326
10.4 COMPANY EVALUATION MATRIX: KEY PLAYERS 327
10.4.1 STARS 327
10.4.2 EMERGING LEADERS 327
10.4.3 PERVASIVE PLAYERS 327
10.4.4 PARTICIPANTS 327
FIGURE 43 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 328
10.4.5 COMPETITIVE FOOTPRINT 329
FIGURE 44 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: OVERALL COMPANY FOOTPRINT 329
TABLE 302 DEVICE FOOTPRINT (1/2) 330
TABLE 303 DEVICE FOOTPRINT (2/2) 331
TABLE 304 CLASS OF DEVICE FOOTPRINT 332
TABLE 305 SERVICE FOOTPRINT 333
TABLE 306 REGIONAL FOOTPRINT 334
10.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES 335
10.5.1 PROGRESSIVE COMPANIES 335
10.5.2 DYNAMIC COMPANIES 335
10.5.3 STARTING BLOCKS 335
10.5.4 RESPONSIVE COMPANIES 335
FIGURE 45 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (SMES/STARTUPS), 2023 336
10.5.5 COMPETITIVE BENCHMARKING 337
TABLE 307 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DETAILED LIST OF KEY STARTUP/SMES 337
TABLE 308 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES 338
10.6 R&D EXPENDITURE OF KEY PLAYERS 339
FIGURE 46 MEDICAL DEVICE MANUFACTURING MARKET: R&D EXPENDITURE OF KEY PLAYERS, 2021–2023 339
10.7 COMPETITIVE SCENARIO 339
10.7.1 PRODUCT LAUNCHES & APPROVALS 339
TABLE 309 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 339
10.7.2 DEALS 340
TABLE 310 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEALS (JANUARY 2020– DECEMBER 2023) 340
10.7.3 EXPANSIONS 341
TABLE 311 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: EXPANSIONS (JANUARY 2020– DECEMBER 2023) 341
10.7.4 OTHER DEVELOPMENTS 342
TABLE 312 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023) 342
10.7.5 BRAND/PRODUCT COMPARATIVE ANALYSIS 343
FIGURE 47 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY DEVICE 343
10.7.5.1 Jabil Inc. 344
10.7.5.2 Flex Ltd. 344
10.7.5.3 Sanmina Corporation 344
10.7.5.4 Integer Holdings Corporation 344
10.7.5.5 Plexus Corp. 344
10.7.5.6 Nipro Corporation 344
10.7.5.7 TE Connectivity Ltd. 344
10.7.6 INVESTMENT LANDSCAPE 345
FIGURE 48 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FUNDING SOARED IN 2022 345
FIGURE 49 MOST VALUED MEDICAL DEVICE CONTRACT MANUFACTURING FIRMS IN 2022 (USD BILLION) 346
FIGURE 50 VALUATION AND FINANCIAL METRICS OF KEY MEDICAL DEVICE CONTRACT MANUFACTURING VENDORS 346
11 COMPANY PROFILES 347
11.1 KEY PLAYERS 347
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 JABIL INC. 347
TABLE 313 JABIL INC.: COMPANY OVERVIEW 347
FIGURE 51 JABIL INC.: COMPANY SNAPSHOT (2023) 348
TABLE 314 JABIL INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 348
TABLE 315 JABIL INC.: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 350
TABLE 316 JABIL INC.: DEALS (JANUARY 2020–DECEMBER 2023) 351
TABLE 317 JABIL INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 351
11.1.2 FLEX LTD. 353
TABLE 318 FLEX LTD.: COMPANY OVERVIEW 353
FIGURE 52 FLEX LTD.: COMPANY SNAPSHOT (2023) 354
TABLE 319 FLEX LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 354
TABLE 320 FLEX LTD.: DEALS (JANUARY 2020–DECEMBER 2023) 355
11.1.3 PLEXUS CORP. 357
TABLE 321 PLEXUS CORP.: COMPANY OVERVIEW 357
FIGURE 53 PLEXUS CORP.: COMPANY SNAPSHOT (2023) 358
TABLE 322 PLEXUS CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 358
TABLE 323 PLEXUS CORP.: DEALS (JANUARY 2020–DECEMBER 2023) 359
TABLE 324 PLEXUS CORP.: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 360
11.1.4 SANMINA CORPORATION 361
TABLE 325 SANMINA CORPORATION: COMPANY OVERVIEW 361
FIGURE 54 SANMINA CORPORATION: COMPANY SNAPSHOT (2023) 362
TABLE 326 SANMINA CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 362
TABLE 327 SANMINA CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 363
TABLE 328 SANMINA CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 363
TABLE 329 SANMINA CORPORATION: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023) 363
11.1.5 INTEGER HOLDINGS CORPORATION 365
TABLE 330 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW 365
FIGURE 55 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022) 366
TABLE 331 INTEGER HOLDINGS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 366
TABLE 332 INTEGER HOLDINGS CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 374
TABLE 333 INTEGER HOLDINGS CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 375
11.1.6 TE CONNECTIVITY LTD. 376
TABLE 334 TE CONNECTIVITY LTD.: COMPANY OVERVIEW 376
FIGURE 56 TE CONNECTIVITY LTD.: COMPANY SNAPSHOT (2023) 377
TABLE 335 TE CONNECTIVITY LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 377
TABLE 336 TE CONNECTIVITY LTD.: SERVICE LAUNCHES (JANUARY 2020–DECEMBER 2023) 378
TABLE 337 TE CONNECTIVITY LTD.: DEALS (JANUARY 2020–DECEMBER 2023) 379
11.1.7 NIPRO CORPORATION 380
TABLE 338 NIPRO CORPORATION: COMPANY OVERVIEW 380
FIGURE 57 NIPRO CORPORATION: COMPANY SNAPSHOT (2023) 381
TABLE 339 NIPRO CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 381
TABLE 340 NIPRO CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 383
TABLE 341 NIPRO CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 384
11.1.8 CELESTICA INC. 385
TABLE 342 CELESTICA INC.: COMPANY OVERVIEW 385
FIGURE 58 CELESTICA INC.: COMPANY SNAPSHOT (2022) 386
TABLE 343 CELESTICA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 386
TABLE 344 CELESTICA INC.: DEALS (JANUARY 2020–DECEMBER 2023) 388
TABLE 345 CELESTICA INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 388
TABLE 346 CELESTICA INC.: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023) 389
11.1.9 WEST PHARMACEUTICAL SERVICES, INC. 390
TABLE 347 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW 390
FIGURE 59 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022) 391
TABLE 348 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 391
TABLE 349 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 393
TABLE 350 WEST PHARMACEUTICAL SERVICES, INC.: DEALS (JANUARY 2020–DECEMBER 2023) 393
TABLE 351 WEST PHARMACEUTICAL SERVICES, INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 394
11.1.10 BENCHMARK ELECTRONICS INC. 395
TABLE 352 BENCHMARK ELECTRONICS INC.: COMPANY OVERVIEW 395
FIGURE 60 BENCHMARK ELECTRONICS INC.: COMPANY SNAPSHOT (2022) 396
TABLE 353 BENCHMARK ELECTRONICS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 396
TABLE 354 BENCHMARK ELECTRONICS INC.: DEALS (JANUARY 2020–DECEMBER 2023) 398
TABLE 355 BENCHMARK ELECTRONICS INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 398
11.1.11 RECIPHARM AB 399
TABLE 356 RECIPHARM AB: COMPANY OVERVIEW 399
TABLE 357 RECIPHARM AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED 399
TABLE 358 RECIPHARM AB: DEALS (JANUARY 2020–DECEMBER 2023) 400
TABLE 359 RECIPHARM AB: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 400
TABLE 360 RECIPHARM AB: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023) 400
11.1.12 GERRESHEIMER AG 401
TABLE 361 GERRESHEIMER AG.: COMPANY OVERVIEW 401
FIGURE 61 GERRESHEIMER AG: COMPANY SNAPSHOT (2022) 402
TABLE 362 GERRESHEIMER AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 402
TABLE 363 GERRESHEIMER AG: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 403
TABLE 364 GERRESHEIMER AG: DEALS (JANUARY 2020–DECEMBER 2023) 403
TABLE 365 GERRESHEIMER AG: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 404
TABLE 366 GERRESHEIMER AG.: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023) 404
11.1.13 KIMBALL ELECTRONICS, INC. 405
TABLE 367 KIMBALL ELECTRONICS, INC.: COMPANY OVERVIEW 405
FIGURE 62 KIMBALL ELECTRONICS, INC.: COMPANY SNAPSHOT (2023) 406
TABLE 368 KIMBALL ELECTRONICS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 406
TABLE 369 KIMBALL ELECTRONICS, INC.: SERVICE LAUNCHES (JANUARY 2020–DECEMBER 2023) 407
TABLE 370 KIMBALL MEDICAL SOLUTIONS: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023) 408
11.1.14 NORTECH SYSTEMS INCORPORATED 409
TABLE 371 NORTECH SYSTEMS INCORPORATED: COMPANY OVERVIEW 409
FIGURE 63 NORTECH SYSTEMS INCORPORATED: COMPANY SNAPSHOT (2022) 409
TABLE 372 NORTECH SYSTEMS INCORPORATED: PRODUCTS/SERVICES/SOLUTIONS OFFERED 410
TABLE 373 NORTECH SYSTEMS INCORPORATED: DEALS (JANUARY 2020–DECEMBER 2023) 410
11.1.15 CARCLO PLC 411
TABLE 374 CARCLO PLC: COMPANY OVERVIEW 411
FIGURE 64 CARCLO PLC: COMPANY SNAPSHOT (2023) 412
TABLE 375 CARCLO PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 412
11.1.16 NOLATO GW, INC. (NOLATO AB) 413
TABLE 376 NOLATO GW, INC.: COMPANY OVERVIEW 413
FIGURE 65 NOLATO GW, INC.: COMPANY SNAPSHOT (2023) 414
TABLE 377 NOLATO GW, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 414
TABLE 378 NOLATO GW, INC.: DEALS (JANUARY 2020–DECEMBER 2023) 415
11.2 OTHER PLAYERS 416
11.2.1 NEMERA 416
TABLE 379 NEMERA: COMPANY OVERVIEW 416
TABLE 380 NEMERA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 416
TABLE 381 NEMERA: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 417
TABLE 382 NEMERA: DEALS (JANUARY 2020–DECEMBER 2023) 418
11.2.2 VIANT MEDICAL HOLDINGS, INC. 419
TABLE 383 VIANT MEDICAL HOLDINGS, INC.: COMPANY OVERVIEW 419
TABLE 384 VIANT MEDICAL HOLDINGS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 419
TABLE 385 VIANT MEDICAL HOLDINGS, INC.: DEALS (JANUARY 2020–DECEMBER 2023) 420
TABLE 386 VIANT MEDICAL HOLDINGS, INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 420
11.2.3 TECOMET, INC. 421
TABLE 387 TECOMET INC.: COMPANY OVERVIEW 421
TABLE 388 TECOMET INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 421
TABLE 389 TECOMET INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 423
11.2.4 SMC LTD. 424
TABLE 390 SMC LTD.: COMPANY OVERVIEW 424
TABLE 391 SMC LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 424
TABLE 392 SMC LTD.: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 425
11.2.5 PHILLIPS-MEDISIZE CORPORATION 426
TABLE 393 PHILLIPS-MEDISIZE CORPORATION: COMPANY OVERVIEW 426
TABLE 394 PHILLIPS-MEDISIZE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 426
TABLE 395 PHILLIPS-MEDISIZE CORPORATION: PRODUCT LAUNCHES (JANUARY 2021-DECEMBER 2021) 427
TABLE 396 PHILLIPS-MEDISIZE CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 427
TABLE 397 PHILLIPS-MEDISIZE CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 428
11.2.6 TESSY PLASTICS CORP. 429
TABLE 398 TESSY PLASTICS CORP.: COMPANY OVERVIEW 429
TABLE 399 TESSY PLASTICS CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 429
TABLE 400 TESSY PLASTICS CORP.: DEALS 430
11.2.7 MEHOW 431
TABLE 401 MEHOW: COMPANY OVERVIEW 431
TABLE 402 MEHOW: PRODUCTS/SERVICES/SOLUTIONS OFFERED 431
11.2.8 TEKNI-PLEX 433
TABLE 403 TEKNI-PLEX: COMPANY OVERVIEW 433
TABLE 404 TEKNI-PLEX: PRODUCTS/SERVICES/SOLUTIONS OFFERED 433
TABLE 405 TEKNI-PLEX: DEALS (JANUARY 2020–DECEMBER 2023) 434
11.2.9 PETER’S TECHNOLOGY 435
TABLE 406 PETER’S TECHNOLOGY: COMPANY OVERVIEW 435
TABLE 407 PETER’S TECHNOLOGY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 435
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX 437
12.1 DISCUSSION GUIDE 437
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 443
12.3 CUSTOMIZATION OPTIONS 445
12.4 RELATED REPORTS 445
12.5 AUTHOR DETAILS 446
Table of Contents